Recent clinical trials have shown promising results for JAK inhibitors in treating alopecia areata. For instance, two phase 3 trials of baricitinib, a selective JAK1 and JAK2 inhibitor ...

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

The chronicity of alopecia areata is linked to persistent immune dysregulation and genetic predisposition. Panelists discuss how the decision to treat vs observe alopecia areata (AA) depends on ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

The global alopecia treatment market size was valued at USD 3.48 billion in 2024 and is projected to reach from USD 3.62 billion in 2025 to USD 5.20 billion by 2033, growing at a CAGR of 4.1% during ...

Step 1: Mix garlic powder and olive oil in a small bowl. Step 2: Mix it thoroughly until you get a smooth paste. Step 3: ...

The Alopecia Areata market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2020 to 2034. It also ...

Superficial cryotherapy is a novel cold-based treatment that has emerged as a potential therapy for patchy alopecia areata ...

The risk for alopecia areata is increased among patients with lower serum levels of vitamin D and zinc, but no relationship was observed with copper.